Welcome to this new interview developed exclusively for Australia’s Cardiologists.
Stream the interview below, or if you would like to listen to this interview (and others) via Private Podcast, manually enter this unique RSS feed into your podcast directory of choice:
https://www.drivetimeradio.com.au/cardiologypodcast
Click on the ‘Access Private Podcast’ button for full instructions on subscribing to our podcasts.
Cardiology
Transcatheter aortic valve implantation (TAVI) has become pivotal in the cardiology space since its introduction in 2002.
In this interview, we discuss some key updates in the TAVI space, in the form of two new studies:
Study one: A four-year follow-up update on the Evolut Low Risk (LR) randomised controlled trial comparing TAVI to surgical aortic valve replacement (SAVR).
Study two: A first-of-its-kind, randomised, controlled trial looking at improving procedural efficiencies and post-care outcomes of TAVI with the use of protamine – known as the ACE-PROTAVI Study.
An easy listen to gain the key takeaways from these new developments!
Associate Professor & Cardiologist, The Alfred Hospital, Melbourne.
Cardiologist, Alfred Health, Melbourne.
Supported by: Supported by Medtronic. Released July 2024.
Tap the share icon
and select 'Add to Home Screen' to add the site to your home screen for quick access!